Yige Bao

1.8k total citations · 1 hit paper
83 papers, 1.1k citations indexed

About

Yige Bao is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Rheumatology. According to data from OpenAlex, Yige Bao has authored 83 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Surgery, 30 papers in Pulmonary and Respiratory Medicine and 15 papers in Rheumatology. Recurrent topics in Yige Bao's work include Bladder and Urothelial Cancer Treatments (27 papers), Urinary and Genital Oncology Studies (19 papers) and Prostate Cancer Treatment and Research (13 papers). Yige Bao is often cited by papers focused on Bladder and Urothelial Cancer Treatments (27 papers), Urinary and Genital Oncology Studies (19 papers) and Prostate Cancer Treatment and Research (13 papers). Yige Bao collaborates with scholars based in China, Canada and United States. Yige Bao's co-authors include Qiang Wei, Jeremy P. Burton, Gregor Reid, Gregory B. Gloor, Shi Qiu, Xiang Tu, Lu Yang, John D. Denstedt, Yerong Yu and Xinyang Liao and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Biomaterials.

In The Last Decade

Yige Bao

73 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Wnt/β-catenin signaling pathway in carcinogenesis and cancer therapy

2024 127 citations Yige Bao et al. profile →

Peers

Countries citing papers authored by Yige Bao

Since Specialization

Citations

This map shows the geographic impact of Yige Bao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yige Bao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yige Bao more than expected).

Fields of papers citing papers by Yige Bao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yige Bao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yige Bao. The network helps show where Yige Bao may publish in the future.

Co-authorship network of co-authors of Yige Bao

This figure shows the co-authorship network connecting the top 25 collaborators of Yige Bao. A scholar is included among the top collaborators of Yige Bao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yige Bao. Yige Bao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	MAIT cells promote cancer progression and regulatory T cell accumulation in bladder tumor microenvironment 2025 ·Journal for ImmunoTherapy of Cancer ·(unknown), Xuejin Ou, (unknown), (unknown), (unknown), (unknown), Francisco M. Martínez, (unknown), Yige Bao, (unknown), (unknown), Nicholas Power, Timothy J. Scholl, (unknown), Alp Şener, S. M. Mansour Haeryfar	1
2	Discordance in HER2 expression in primary and recurrent/metastatic lesions of upper tract urothelial carcinoma: A study focusing on temporal heterogeneity. 2025 ·Journal of Clinical Oncology ·(unknown), Xinyang Liao, Qihao Wang, Lei Zheng, (unknown), Qiang Wei, Yige Bao	0
3	PD20-11 NEOADJUVANT TORIPALIMAB AND CHEMOTHERAPY FOR LOCALLY ADVANCED UPPER URINARY TRACT CARCINOMA: A PILOT STUDY FOR A PHASE II TRIAL 2024 ·The Journal of Urology ·Xinyang Liao, Yige Bao, Qiang Wei	1
4	The tumor immune profile of bladder cancer (BC) with HER2 over-expression and the investigation into RC48-ADC versus BCG in high-risk non-muscle invasive BC with HER2 over-expression. 2024 ·Journal of Clinical Oncology ·(unknown), Junru Chen, Haolin Liu, (unknown), Yige Bao, Banghua Liao, Hao Zeng	3
5	Adjuvant or rescue disitamab vedotin (RC48-ADC) for high-risk non-muscle invasive bladder cancer with HER2 overexpression: A phase II multi-center study. 2024 ·Journal of Clinical Oncology ·Junru Chen, (unknown), (unknown), Chenhao Xu, Qiang Wei, Jiyan Liu, Zhenhua Liu, Pengfei Shen, Yige Bao, Pengfei Zhang, Banghua Liao, Jin Yao, Ni Chen, Kaijie Wu, Xiaodong Liu, Hao Zeng	1
6	DNA methylation urine test in the diagnosis of upper tract urothelial carcinoma: a systematic review and meta-analysis 2024 ·International Journal of Surgery ·(unknown), Xiaoli Wang, Xinyang Liao, Ye Chen, Zeyu Chen, (unknown), Jianzhong Ai, Qiang Wei, Yige Bao	0
7	Current treatment for male infertility: an umbrella review of systematic reviews and meta-analyses 2024 ·Asian Journal of Andrology ·(unknown), (unknown), Qihao Wang, Xinyang Liao, Xingyuan Wang, Chichen Zhang, Liangren Liu, Qiang Wei, Yige Bao	3
8	WUTSUP-02-II-Neo-Dis-Tis: Investigating the efficacy and safety of neoadjuvant tislelizumab plus disitamab vedotin with adjuvant tislelizumab in upper urinary tract carcinoma—A phase II multi-center study. 2024 ·Journal of Clinical Oncology ·Yige Bao, Xinyang Liao, Peng Zhang, Hao Zeng, Jiyan Liu, Qiang Wei	0
9	Intelligent Inspection Guidance of Urethral Endoscopy Based on SLAM with Blood Vessel Attentional Features 2024 ·Cognitive Computation ·(unknown), (unknown), (unknown), (unknown), Yige Bao	2
10	Comparative analysis of salvage partial nephrectomy versus radical nephrectomy after the failure of initial partial nephrectomy 2023 ·Urologic Oncology Seminars and Original Investigations ·Jiwei Huang, (unknown), Cuijian Zhang, Yige Bao, Xiaoyi Hu, Xiongjun Ye, Minfeng Chen, Ping Wang, Jitao Wu, (unknown), Qi Tang, (unknown), Bing Zheng, (unknown), Jianming Guo, Yong Huang, Qiang Wei, Zhisong He, Wei Xue	3
11	Recent advances in single-site/incision robotic-assisted radical prostatectomy 2023 ·European Journal of Surgical Oncology ·(unknown), (unknown), Xu Hu, Yige Bao, Dong Wang, Yifan Chang	3
12	Effectiveness and safety of immune checkpoint inhibitor monotherapy in advanced upper tract urothelial carcinoma: A multicenter, retrospective, real‐world study 2023 ·Cancer Medicine ·(unknown), (unknown), (unknown), Shuai Jiang, (unknown), (unknown), Hailong Hu, (unknown), (unknown), Zhenyu Wang, Bing Zheng, Jian Huang, (unknown), (unknown), Yige Bao, (unknown), Jianming Guo, Minfeng Chen, Qiang Wei, Jiwei Huang, Wei Xue	4
13	Transperineal magnetic resonance imaging targeted biopsy versus transrectal route in the detection of prostate cancer: a systematic review and meta-analysis 2023 ·Prostate Cancer and Prostatic Diseases ·(unknown), Xiang Tu, (unknown), Jianjun Ye, Tianhai Lin, (unknown), Lu Yang, Shi Qiu, Yige Bao, (unknown)	20
14	A systematic review and meta-analysis for human epidermal growth factor receptor 2 on upper tract urothelial carcinoma patients 2023 ·Tumori Journal ·(unknown), Xinyang Liao, Yu Qiu, Qiang Wei, Yige Bao	3
15	Chronological Liquid Biopsy Reveals the Impact of Platinum-Based Chemotherapy on a Prostate Cancer Patient’s CDK12 Mutation: A Case Report 2022 ·OncoTargets and Therapy ·Sha Zhu, Yige Bao, Linmao Zheng, Jinge Zhao, Yahong Chen, Rui Huang, Guangxi Sun, (unknown), Xingming Zhang, Jiayu Liang, Junru Chen, Zhipeng Wang, Yuchao Ni, Ni Chen, Pengfei Shen, Hao Zeng	1
16	Body Composition Parameters May Be Prognostic Factors in Upper Urinary Tract Urothelial Carcinoma Treated by Radical Nephroureterectomy 2021 ·Frontiers in Oncology ·(unknown), Zeyu Chen, (unknown), Xingyuan Wang, (unknown), Liang Zhou, (unknown), Lu Yang, Hui Zhuo, Yige Bao, Qiang Wei	6
17	Partial nephrectomy vs cryoablation for T1a renal cell carcinoma: A comparison of survival benefit stratified by tumour size 2019 ·Cancer Epidemiology ·Xinyang Liao, Shi Qiu, Wanyu Wang, Xiaonan Zheng, Kun Jin, Shiyu Zhang, Yige Bao, Lu Yang, Qiang Wei	6
18	Characteristics and regional difference of Chinese upper tract urothelial carcinoma patients: a multi-center study by CUDA-UTUC Collaborative Group 2017 ·Zhonghua miniao waike zazhi ·Dong Fang, Jiwei Huang, Yige Bao, Runzhuo Ma, Xuesong Li, Bao Guan, (unknown), (unknown), (unknown), Yunxiang Li, (unknown), Jin Zhang, Zhenhua Liu, Gengyan Xiong, Lei Zhang, Han Hao, (unknown), (unknown), Qiang Wei, Wei Xue	2
19	Immunogenicity of interleukin 12 and DNA vaccine prime-BCG boost against Mycobacterium tuberculosis 2010 ·International Journal of Infectious Diseases ·Lang Bao, (unknown), Yige Bao	3
20	Free fatty acids induce endothelial dysfunction and activate protein kinase C and nuclear factor-κB pathway in rat aorta 2010 ·International Journal of Cardiology ·Hua Li, Hongliang Li, Yige Bao, (unknown), Yerong Yu	66

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact